CORTISPORIN 400 UNT / 10 mg / 3.5 mg / 5000 UNT per GM Topical Ointment
RxNorm 688704
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 688704 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: CORTISPORIN 400 UNT / 10 mg / 3.5 mg / 5000 UNT per GM Topical Ointment.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Bacitracin 0.4 UNT/MG / hydrocortisone 0.01 mg/MG / neomycin 0.0035 mg/MG / polymyxin B 5 UNT/MG Topical Ointment [Cortisporin Ointment]
(Atom ID: 12357878)
PSN
Prescribable Name (PSN):
CORTISPORIN 400 UNT / 10 mg / 3.5 mg / 5000 UNT per GM Topical Ointment
(Atom ID: 6391028)
SY
Synonym (SY):
Cortisporin Ointment (bacitracin 0.4 UNT/MG / hydrocortisone 1 % / neomycin 0.35 % / polymyxin B 5 UNT/MG) Topical Ointment
(Atom ID: 3629327)
SY
Synonym (SY):
Cortisporin Ointment (bacitracin 400 UNT/ hydrocortisone 10 mg / neomycin 3.5 mg/ polymyxin B 5000 UNT) per GM Topical Ointment
(Atom ID: 3629326)
Patient Education
Neomycin, Polymyxin, Bacitracin, and Hydrocortisone Topical
Neomycin, polymyxin, bacitracin, and hydrocortisone combination is used to treat skin infections caused by certain bacteria and to treat the redness, swelling, itching, and discomfort of various skin conditions. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. They work by stopping the growth of bacteria. Hydrocortisone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
[Learn More]
* Please review the disclaimer below.